Long-term safety of ranibizumab in neovascular age-related macular degeneration
- PMID: 24001549
- DOI: 10.1016/j.ophtha.2013.06.031
Long-term safety of ranibizumab in neovascular age-related macular degeneration
Comment in
-
Author reply: To PMID 23021093.Ophthalmology. 2013 Sep;120(9):e69. doi: 10.1016/j.ophtha.2013.06.032. Ophthalmology. 2013. PMID: 24001550 No abstract available.
Comment on
-
The SECURE study: long-term safety of ranibizumab 0.5 mg in neovascular age-related macular degeneration.Ophthalmology. 2013 Jan;120(1):130-9. doi: 10.1016/j.ophtha.2012.07.026. Epub 2012 Sep 25. Ophthalmology. 2013. PMID: 23021093 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
